News
Artificial intelligence (AI) helped develop Pirelli's tires of the future, its new-generation P Zero product line, in record ...
6d
Pharmaceutical Technology on MSNPharma’s AI prospects get nudged into the future with EU’s AI actAct may protect citizens, but some experts in the life sciences industry are worried about the potential challenges it may ...
AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.
Startup Persist AI, which launched a cloud lab to accelerate pharmaceutical formulation development, raised $12 million in a ...
23h
Free Malaysia Today on MSNFirst AI-generated drugs may reach market by 2030, says Insilico CEOThe pharmaceutical industry has long touted the promise of AI in slashing time and costs in the research and development ...
SACRAMENTO, Calif., May 19, 2025 /PRNewswire/ -- Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), today ...
Imagene is the Innovation award winner in the Precision Oncology category in the 2025 Pharmaceutical Excellence Awards.
Not unlike Regeneron's acquisition of 23andMe, Predictive Oncology's AI-driven breakthroughs reflect a broader transformation ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
7d
Pharmaceutical Technology on MSNBoehringer partners Tempus AI to enhance cancer therapy pipelineBoehringer Ingelheim has entered a multi-year partnership with Tempus AI to progress its cancer treatment pipeline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results